Medications

FDA panel again rejects wider use of J&J's Xarelto

A panel of Food and Drug Administration experts again opposed expanding use of Johnson & Johnson's blood thinner Xarelto to reduce dangerous blood clots in a new group of patients, those with acute coronary artery disease.

Jan 16, 2014
popularity not rated yet | comments 0

NCPA: Access to controlled substances often delayed

(HealthDay)—Most pharmacists report experiencing multiple delays or issues with their controlled substance orders, according to the results of the National Community Pharmacists Association (NCPA) Controlled ...

Jan 16, 2014
popularity not rated yet | comments 0

FDA warns of fires from wart removers

(HealthDay)—Flammable over-the-counter wart removers have started fires, injuring at least 10 people in recent years, the U.S. Food and Drug Administration says.

Jan 16, 2014
popularity not rated yet | comments 0

States urged to register compounding pharmacies

The federal government has sent letters to states and other stakeholders across the country calling on them to encourage compounding pharmacies to register as a producer of sterile drugs in an effort to protect the public.

Jan 10, 2014
popularity not rated yet | comments 0